The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis ; volume:9 ; number:1 ; day:14 ; month:9 ; year:2011 ; pages:1 ; date:12.2011
Pediatric rheumatology ; 9, Heft 1 (14.9.2011), 1, 12.2011
- Urheber
-
Trachana, M.
Triantafyllou, P.
Vraka, A.
Kaitalidou, E.
Pratsidou-Gertsi, P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-9-S1-P149
- URN
-
urn:nbn:de:101:1-2019062621211144656267
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trachana, M.
- Triantafyllou, P.
- Vraka, A.
- Kaitalidou, E.
- Pratsidou-Gertsi, P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
TH17-phenotypes of juvenile idiopathic arthritis
Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach
Impact of juvenile idiopathic arthritis on schooling
Juvenile idiopathic arthritis-associated uveitis
Haptoglobin in Juvenile Idiopathic Arthritis
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
TH17-phenotypes of juvenile idiopathic arthritis
Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach
Impact of juvenile idiopathic arthritis on schooling
Juvenile idiopathic arthritis-associated uveitis
Haptoglobin in Juvenile Idiopathic Arthritis
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
TH17-phenotypes of juvenile idiopathic arthritis
Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach
Impact of juvenile idiopathic arthritis on schooling
Juvenile idiopathic arthritis-associated uveitis